Patents by Inventor Christopher Lowe
Christopher Lowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11961538Abstract: Systems and methods are presented for efficient cross-fading of compressed domain information streams on a user/client device. Exemplary systems may provide cross-fade between AAC/Enhanced AAC Plus information streams, between MP3 information streams, or between information streams of unmatched formats. These systems are distinguished in that cross-fade is directly applied to compressed bitstreams so a single decode operation is performed on the resulting bitstream. Thus, a set of frames from each input stream associated with the time interval in which a cross fade is decoded, and combined and recoded with a cross fade or other effect now in the compressed bitstream. Once sent through the client device's decoder, the user hears the transitional effect. The only input data that is decoded and processed is that associated with the portion of each stream used the crossfade, blend or other interstitial, and thus the vast majority of input streams are left compressed.Type: GrantFiled: November 9, 2021Date of Patent: April 16, 2024Assignee: Sirius XM Radio Inc.Inventors: Raymond Lowe, Mark Kalman, Deepen Sinha, Christopher Ward
-
Patent number: 11921778Abstract: Systems, methods and apparatus for generating music recommendations based on combining song and user influencers with channel rule characterizations are presented. Such systems and methods output a playlist, which may be delivered as an information stream of audio on a user or client device, such as a telephone or smartphone, tablet, computer or MP3 player, or any consumer device with audio play capabilities. The playlist may comprise various individual audio clips of one genre or type, such as songs, or of multiple types, such as music, talk, sports and comedy. The individual audio clips may be ordered by a sequencer, which, using large amounts of data, generates both (i) user independent and (i) user dependent influencer weightings for each clip, and then combines all of such influencer weightings into a combined play weighting W for a given audio clip, for a given user.Type: GrantFiled: December 28, 2021Date of Patent: March 5, 2024Assignee: Sirius XM Radio Inc.Inventors: Raymond Lowe, Christopher Ward
-
Publication number: 20210369864Abstract: The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.Type: ApplicationFiled: August 10, 2021Publication date: December 2, 2021Applicant: Rutgers, The State University of New JerseyInventors: Christopher Lowe, David I. Shreiber, Emily DiMartini, Adam Gormley
-
Patent number: 11020491Abstract: The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.Type: GrantFiled: June 14, 2018Date of Patent: June 1, 2021Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEYInventors: Christopher Lowe, David I. Shreiber, Emily DiMartini, Adam Gormley
-
Patent number: 10646772Abstract: Apparatus, systems, and methods for delivery of an automatically clearing composition in a balloon.Type: GrantFiled: May 15, 2019Date of Patent: May 12, 2020Inventor: Taylor Christopher Lowe
-
Publication number: 20180360989Abstract: The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.Type: ApplicationFiled: June 14, 2018Publication date: December 20, 2018Applicant: Rutgers, The State University of New JerseyInventors: Christopher Lowe, David I. Shreiber, Emily DiMartini, Adam Gormley
-
Patent number: 9797644Abstract: A collapsible and expandable ice dispensing tubing apparatus having a first end and an opposite second end, the apparatus comprising: a hollow flexible body having a first opening formed at the first end and an opposite second opening formed at the second end, the body comprising a sheath and at least one reinforcing member for communication through the body from the first opening to the second opening; a first collar formed on the body at the first end and an opposite second collar formed on the body at the second end; and a fastener configured to selectively engage the first and second collars so as to selectively maintain the apparatus in a collapsed configuration. The apparatus may be employed in conjunction with other devices for selectively dispensing ice from an ice dispensing machine into a container.Type: GrantFiled: March 9, 2017Date of Patent: October 24, 2017Inventor: Taylor Christopher Lowe
-
Publication number: 20160096895Abstract: This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a KD of 10 pM or less when measured by Kinexa™. The binding members are useful for, inter alia, treatment of disorders mediated by IL-1R1 including rheumatoid arthritis, asthma and chronic obstructive pulmonary disease (COPD).Type: ApplicationFiled: October 23, 2015Publication date: April 7, 2016Inventors: JAMIE IAIN CAMPBELL, DUNCAN JAMES COCHRANE, DONNA KIRSTY FINCH, MARIA ANASTASIA TERESA GROVES, DAVID CHRISTOPHER LOWE, SIMON CHARLES CRUWYS
-
Patent number: 9200074Abstract: This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a KD of 10 pM or less when measured by Kinexa™. The binding members are useful for, inter alia, treatment of disorders mediated by IL-1R1 including rheumatoid arthritis, asthma and chronic obstructive pulmonary disease (COPD).Type: GrantFiled: April 16, 2014Date of Patent: December 1, 2015Assignee: MEDIMMUNE LIMITEDInventors: Jamie Iain Campbell, Duncan James Cochrane, Donna Kirsty Finch, Maria Anastasia Teresa Groves, David Christopher Lowe, Simon Charles Cruwys
-
Publication number: 20140212429Abstract: This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a KD of 10 pM or less when measured by Kinexa™. The binding members are useful for, inter alia, treatment of disorders mediated by IL-1R1 including rheumatoid arthritis, asthma and chronic obstructive pulmonary disease (COPD).Type: ApplicationFiled: April 16, 2014Publication date: July 31, 2014Applicant: MEDIMMUNE LIMITEDInventors: JAMIE IAIN CAMPBELL, DUNCAN JAMES COCHRANE, DONNA KIRSTY FINCH, MARIA ANASTASIA TERESA GROVES, DAVID CHRISTOPHER LOWE, SIMON CHARLES CRUWYS
-
Patent number: 8741604Abstract: This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a KD of 10 pM or less when measured by Kinexa™. The binding members are useful for, inter alia, treatment of disorders mediated by IL-1R1 including rheumatoid arthritis, asthma and chronic obstructive pulmonary disease (COPD).Type: GrantFiled: September 14, 2012Date of Patent: June 3, 2014Assignee: Medimmune LimitedInventors: Jamie Iain Campbell, Duncan James Cochrane, Donna Kirsty Finch, Maria Anastasia Teresa Groves, David Christopher Lowe, Simon Charles Cruwys
-
Publication number: 20130293439Abstract: An antenna for wireless telecommunication comprises a piezoelectric material layer, the piezoelectric material layer being formed such that when an electromagnetic wave is applied thereto, the first piezoelectric material layer is excited at the frequency of the electromagnetic wave. The antenna also comprises an acoustic cavity layer arranged to collect the acoustic energy received from the first piezoelectric layer and first and second electrode layers positioned on either side of the acoustic cavity layer, the electrode layers being arranged to transfer electrical energy to and from both the piezoelectric material layer and the acoustic cavity layer.Type: ApplicationFiled: April 27, 2011Publication date: November 7, 2013Applicant: Sparq Wireless Solutions Pte, Ltd.Inventors: Kalyan Sarma, Christopher Lowe, Adrian Stevenson
-
Publication number: 20130177555Abstract: Provided are monomeric polypeptides comprising variant Fc regions and methods of using them. In certain embodiments, monomeric polypeptides of the invention are fusion proteins. In certain embodiments, monomeric polypeptides of the invention are antibodies.Type: ApplicationFiled: August 11, 2011Publication date: July 11, 2013Applicant: MEDIMMUNE LIMITEDInventors: Ian Wilkinson, Carl Innes Webster, David Christopher Lowe
-
Publication number: 20130078717Abstract: This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a KD of 10 pM or less when measured by Kinexa™. The binding members are useful for, inter alia, treatment of disorders mediated by IL-1R1 including rheumatoid arthritis, athma and chronic obstructive pulmonary disease (COPD).Type: ApplicationFiled: September 14, 2012Publication date: March 28, 2013Applicant: MedImmune LimitedInventors: Jamie Iain CAMPBELL, Duncan James Cochrane, Donna Kirsty Finch, Maria Anastasia Teresa Groves, David Christopher Lowe, Simon Charles Cruwys
-
Patent number: 8399483Abstract: A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions, said substituted derivatives having the general formulaType: GrantFiled: December 17, 2008Date of Patent: March 19, 2013Assignee: UCB Pharma S.A.Inventors: Daniel Rees Allen, George Martin Buckley, Roland Bürli, John Richard Davenport, Natasha Kinsella, Christopher James Lock, Christopher Lowe, Stephen Robert Mack, William Ross Pitt, Andrew James Ratcliffe, Marianna Dilani Richard, Verity Margaret Sabin, Andrew Sharpe, Laura Jane Tait, Graham John Warrellow, Sophie Caroline Williams
-
Patent number: 8324204Abstract: A series of 5,6-dihydro-1-benzothiophen-7(4H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.Type: GrantFiled: June 4, 2007Date of Patent: December 4, 2012Assignee: UCB Pharma SAInventors: Rikki Peter Alexander, Stuart Bailey, Stephen Brand, Daniel Christopher Brookings, Julien Alistair Brown, Alan Findlay Haughan, Natasha Kinsella, Christopher Lowe, Stephen Robert Mack, William Ross Pitt, Marianna Dilani Richard, Andrew Sharpe, Laura Jane Tait
-
Patent number: 8298533Abstract: This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a KD of 10 pM or less when measured by Kinexa™. The binding members are useful for, inter alia, treatment of disorders mediated by IL-1R1 including rheumatoid arthritis, asthma and chronic obstructive pulmonary disease (COPD).Type: GrantFiled: November 5, 2009Date of Patent: October 30, 2012Assignee: MedImmune LimitedInventors: Jamie Iain Campbell, Duncan James Cochrane, Donna Kirsty Finch, Maria Anastasia Teresa Groves, David Christopher Lowe, Simon Charles Cruwys
-
Publication number: 20110105508Abstract: A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.Type: ApplicationFiled: December 17, 2008Publication date: May 5, 2011Applicant: UCB PHARMA, S.A.Inventors: Daniel Rees Allen, George Martin Buckley, Roland Bürli, John Richard Davenport, Natasha Kinsella, Christopher James Lock, Christopher Lowe, Stephen Robert Mack, William Ross Pitt, Andrew James Ratcliffe, Marianna Dilani Richard, Verity Margaret Sabin, Andrew Sharpe, Laura Jane Tait, Graham John Warrelow, Sophie Caroline Williams
-
Publication number: 20100305066Abstract: A series of 5,6-dihydro-1-benzothiophen-7(4H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.Type: ApplicationFiled: June 4, 2007Publication date: December 2, 2010Applicant: UCB PHARMA S.A.Inventors: Rikki Peter Alexander, Stuart Bailey, Stephen Brand, Daniel Christopher Brookings, Julien Alistair Brown, Alan Findlay Haughan, Natasha Kinsella, Christopher Lowe, Stephen Robert Mack, William Ross Pitt, Marianna Dilani Richard, Andrew Sharpe, Laura Jane Tait
-
Publication number: 20100221257Abstract: This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a KD of 10 pM or less when measured by Kinexa™. The binding members are useful for, inter alia, treatment of disorders mediated by IL-1R1 including rheumatoid arthritis, athma and chronic obstructive pulmonary disease (COPD).Type: ApplicationFiled: November 5, 2009Publication date: September 2, 2010Applicant: MEDIMMUNE LIMITEDInventors: Jamie Iain Campbell, Duncan James Cochrane, Donna Kirsty Finch, Maria Anastasia Teresa Groves, David Christopher Lowe, Simon Charles Cruwys